King Bio Recalls Dr. King's SafeCare Rx Candida Due to Microbial Contamination
King Bio Inc. is recalling Dr. King's SafeCare Rx Candida bottles due to microbial contamination. The product was distributed in the U.S., Canada, and Australia.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of at least 4 per the rubric.
Plain-English summary
King Bio Inc. is voluntarily recalling 4,648 bottles of Dr. King's SafeCare Rx Candida, 8 fl. oz. (236 mL). The recall is being conducted because the product is subject to microbial contamination. The affected product is identified by NDC 57955-6207-8 and UPC 357955620686.
The recalled product was distributed nationwide in the United States, as well as in Canada and Australia. Specific lots affected include 050216AB (Exp. 05/19), 071416A (Exp. 07/19), 101716C (Exp. 10/19), 030117F (Exp. 03/20), and 120217C (Exp. 12/19).
Consumers who have purchased this product should stop using it and contact King Bio Inc. for further instructions or a refund.
The recalled product
- Product
- Dr. King's SafeCare Rx Candida, 8 fl. oz. (236 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955620686, NDC 57955-6207-8
- Manufacturer
- King Bio Inc.
- Category
- Drug — Supplement
- Hazard
- Affected units
- 4,648
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lots: 050216AB Exp. 05/19
- 071416A Exp. 07/19
- 101716C Exp. 10/19
- 030117F Exp. 03/20
- 120217C Exp. 12/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 465 recalled by King Bio Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 465 products in this recall →Related recalls
Same manufacturer · King Bio Inc.
See all →- CriticalKing Bio Recalls Dr. King's SafeCare Rx Calloused Due to Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Spray Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalKing Bio Recalls Heartburn Relief for Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Product Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalDr. King's Advanced Arnica Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
Same hazard · microbial contamination
See all →- SevereMedtronic Recalls Grafton DBM Allografts Due to Donor Microbial Presence
FDA (Devices) · 2026-10-21
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- SevereMedline Ultrasound Breast Pack Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- CriticalOptimal Balance Pharmacy Recalls Contaminated Glutathione Injection Vials
FDA (Drugs) · 2026-09-09
Similar recalls
- HighInjectable drug product recalled for lack of sterility assurance
FDA (Drugs) · 2022-09-21
- SevereRed Mountain Compounding Recalls S-Hydroxocobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-11-13
- SevereCenturion Labs Recalls Ninjacof-A Oral Solution Due to Microbial Contamination
FDA (Drugs) · 2017-09-20
- SevereSafecor Health Recalls Doxycycline Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2017-06-21
- ModerateSafecor Recalls Acyclovir 400mg Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2017-06-21
- SevereRXQ Compounding Recalls Hydroxocobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2019-08-14